Litigation Details for Genzyme Corp. v. Apotex Corp. (D. Del. 2018)
✉ Email this page to a colleague
Genzyme Corp. v. Apotex Corp. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-11-13 |
| Court | District Court, D. Delaware | Date Terminated | 2021-03-10 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 7,196,205 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Genzyme Corp. v. Apotex Corp.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Genzyme Corp. v. Apotex Corp. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-11-13 | 1 | infringement of U.S. Patent No. 7,196,205 (the “’205 patent”) under the Patent Laws of the United States… THE PATENT-IN-SUIT 21. On March 27, 2007, the ’205 patent, titled “Synthesis…United States Patent and Trademark Office (“PTO”). A true and correct copy of the ’205 patent is attached… the ’205 patent. 37. Defendants had actual knowledge of the ’205 patent prior to …expiration of the ’205 patent would constitute an act of infringement of the ’205 patent. Defendants had | External link to document | |
| 2018-11-13 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,196,205 B2. (sar) (Entered:…2018 11 March 2021 1:18-cv-01795 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
